Durham, NC 的 結腸癌 臨床試驗
12 項針對 結腸癌 的研究正在 Durham(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Durham
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
招募中3 期
- Duke Cancer Center - Investigational Chemotherapy Service, Durham
- Duke Cancer Center, Durham
- Duke University Hospital - Vascular Interventional Radiology, Durham
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
招募中3 期
- The University of North Carolina At Chapel Hill, Chapel Hill · 距離 10 英里
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
招募中觀察性研究
- UNC- Chapel Hill, Chapel Hill · 距離 10 英里
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
招募中2/3 期
- Duke University Medical Center, Durham
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距離 10 英里
Shield Post-Approval Study Protocol
招募中觀察性研究歡迎健康志工
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
- University of North Carolina at Chapel Hill, Chapel Hill · 距離 10 英里
- University of North Carolina at Chapel Hill, Hillsborough · 距離 13 英里
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
招募中1 期
- Xencor Investigative Site, Durham
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
招募中1 期
- Research Site, Durham
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
招募中1 期
- Duke Cancer Center, Durham
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
招募中3 期
- GSK Investigational Site, Durham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Chapel Hill · 距離 10 英里
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
招募中2 期
- University of North Carolina, Chapel Hill · 距離 10 英里
其他城市的 結腸癌 試驗
- Boston, MA22 項研究
- New York City, NY22 項研究
- Houston, TX20 項研究
- Los Angeles, CA16 項研究
- Nashville, TN16 項研究
- St. Louis, MO15 項研究
- Arlington, VA15 項研究
- Chicago, IL14 項研究
- San Antonio, TX14 項研究
- Baldwin Park, CA14 項研究
- Baltimore, MD13 項研究
- Tampa, FL13 項研究
Durham 的其他研究
- 乳癌64 項研究
- 癌症(所有類型)58 項研究
- 非小細胞肺癌39 項研究
- 多發性骨髓瘤37 項研究
- 急性髓系白血病33 項研究
- 轉移性癌症33 項研究
- 前列腺癌32 項研究
- 肺癌32 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 慢性淋巴性白血病27 項研究
- 心臟衰竭26 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。